OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Chemistry is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform	309
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020	241
Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads	181
Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification	160
Clinical Performance of Two SARS-CoV-2 Serologic Assays	158
Inflammation in Atherosclerosis—No Longer a Theory	158
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease	130
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation	122
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays	106
Limits of Detection of 6 Approved RT–PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)	106
Lipoprotein(a) and Cardiovascular Disease	104
Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity	96
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies	96
Rapid Detection of SARS-CoV-2 by Low Volume Real-Time Single Tube Reverse Transcription Recombinase Polymerase Amplification Using an Exo Probe with an Internally Linked Quencher (Exo-IQ)	95
SARS-CoV-2 Serology: Much Hype, Little Data	83
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning	75
Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and Diagnosis	69
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Cl	69
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test	62
The Role of Metagenomics and Next-Generation Sequencing in Infectious Disease Diagnosis	61
Metagenomic Analysis Reveals Clinical SARS-CoV-2 Infection and Bacterial or Viral Superinfection and Colonization	61
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group	59
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease	58
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay	58
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections	54

Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2	51
Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation	49
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaborati	48
Antibody Profiles in Mild and Severe Cases of COVID-19	48
Cautionary Note on Contamination of Reagents Used for Molecular Detection of SARS-CoV-2	46
Lateral Flow Assays in Infectious Disease Diagnosis	46
Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation	45
Myocardial Injury and the Release of Troponins I and T in the Blood of Patients	44
Efficiency Correction Is Required for Accurate Quantitative PCR Analysis and Reporting	42
Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis	41
The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19	40
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test	39
Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)	38
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?	38